Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study. - Tousek, P; Rokyta, R; Tesarova, J (Acute Card Care, 2011)
et al.